Polymer Capital Management »

Sab Biotherapeutics shares owned by Polymer Capital Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Polymer Capital Management from 13F filings

Historical chart of Polymer Capital Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Polymer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Polymer Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 307k 3.90

More positions owned by Polymer Capital Management

Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Sandisk Corp (SNDK)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Applied Materials (AMAT)
Micron Technology (MU)
Pdd Holdings Sponsored Ads (PDD)
Bloom Energy Corp Com Cl A (BE)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Roundhill Etf Trust Memory Etf
Alnylam Pharmaceuticals (ALNY)
Advanced Micro Devices (AMD)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Frontline (FRO)

View all positions for Polymer Capital Management

Top funds holding Sab Biotherapeutics

Caligan Partners
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
RA Capital Management
Balyasny Asset Management
BlackRock
Vanguard Capital Management
Commodore Capital
Millennium Management
Spruce Street Capital
Sessa Capital IM
Affinity Asset Advisors
Boothbay Fund Management
Geode Capital Management

View all funds holding Sab Biotherapeutics